Relation of body mass index to on-treatment (Clopidogrel + Aspirin) platelet reactivity

American Journal of Cardiology

Volumn 108, Issue 6, 2011, Pages 766-771

  Gaglia Jr , Michael A ^a   Torguson, Rebecca ^a   Pakala, Rajbabu ^a   Xue, Zhenyi ^a   Sardi, Gabriel ^a   Mahmoudi, Michael ^a   Suddath, William O ^a   Kent, Kenneth M ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ANALYTICAL EQUIPMENT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING PARAMETERS; BODY MASS; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PLATELET REACTIVITY INDEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; ASPIRIN; BODY MASS INDEX; CELL ADHESION MOLECULES; CORONARY DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TICLOPIDINE;

EID: 80052200835     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.04.029     Document Type: Article

References (31)

1. A.R. Shuldiner, J.R. O'Connell, K.P. Bliden, A. Gandhi, K. Ryan, R.B. Horenstein, C.M. Damcott, R. Pakyz, U.S. Tantry, Q. Gibson, T.I. Pollin, W. Post, A. Parsa, B.D. Mitchell, N. Faraday, W. Herzog, and P.A. Gurbel Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 2009 849 857
2. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, J.T. Brandt, J.R. Walker, E.M. Antman, W. Macias, E. Braunwald, and M.S. Sabatine Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
3. T. Simon, C. Verstuyft, M. Mary-Krause, L. Quteineh, E. Drouet, N. Méneveau, P.G. Steg, J. Ferrires, N. Danchin, and L. Becquemont Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
4. D.J. Angiolillo, A. Fernández-Ortiz, E. Bernardo, C. Barrera Ramírez, M. Sabaté, C. Fernandez, R. Hernández- Antolín, J. Escaned, F. Alfonso, and C. Macaya Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol 16 2004 169 174 (Pubitemid 38456448)
5. W. Hochholzer, D. Trenk, H.P. Bestehorn, B. Fischer, C.M. Valina, M. Ferenc, M. Gick, A. Caputo, H.J. Bttner, and F.J. Neumann Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement J Am Coll Cardiol 48 2006 1742 1750 (Pubitemid 44648629)
6. D. Sibbing, O. von Beckerath, A. Schömig, A. Kastrati, and N. von Beckerath Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention Am J Cardiol 100 2007 203 205 (Pubitemid 47041981)
7. T. Cuisset, C. Frere, J. Quilici, P.E. Morange, L. Camoin, L. Bali, M. Lambert, I. Juhan-Vague, M.C. Alessi, and J.L. Bonnet Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response Thromb Res 123 2009 597 603
8. R.M. Krauss, M. Winston, B.J. Fletcher, and S.M. Grundy Obesity: impact on cardiovascular disease Circulation 98 1998 1472 1476 (Pubitemid 28462809)
9. L. Gruberg, N.J. Weissman, R. Waksman, S. Fuchs, R. Deible, E.E. Pinnow, L.M. Ahmed, K.M. Kent, A.D. Pichard, W.O. Suddath, L.F. Satler, and J. Lindsay Jr The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39 2002 578 584 (Pubitemid 34158151)
10. D.B. Diercks, M.T. Roe, J. Mulgund, C.V. Pollack Jr, J.D. Kirk, W.B. Gibler, E.M. Ohman, S.C. Smith Jr, W.E. Boden, and E.D. Peterson The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative Am Heart J 152 2006 140 148 (Pubitemid 44040849)
11. T. Lancefield, D.J. Clark, N. Andrianopoulos, A.L. Brennan, C.M. Reid, J. Johns, M. Freeman, K. Charter, S.J. Duffy, A.E. Ajani, J. Proietto, and O. Farouque Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry JACC Cardiovasc Interv 3 2010 660 668
12. H. Mani, B. Luxembourg, C. Klffling, M. Erbe, and E. Lindhoff-Last Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements J Clin Pathol 58 2005 747 750 (Pubitemid 40956832)
13. B. Linnemann, J. Schwonberg, H. Mani, S. Prochnow, and E. Lindhoff-Last Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary J Thromb Haemost 6 2008 677 683 (Pubitemid 351404936)
14. L. Bonello, U.S. Tantry, R. Marcucci, R. Blindt, D.J. Angiolillo, R. Becker, D.L. Bhatt, M. Cattaneo, J.P. Collet, T. Cuisset, C. Gachet, G. Montalescot, L.K. Jennings, D. Kereiakes, D. Sibbing, D. Trenk, J.W. Van Werkum, F. Paganelli, M.J. Price, R. Waksman, and P.A. Gurbel Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
15. P.A. Gurbel, M.J. Antonino, K.P. Bliden, J. Dichiara, T.A. Suarez, A. Singla, and U.S. Tantry Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target Platelets 19 2008 595 604
16. P.A. Gurbel, K.P. Bliden, W. Samara, J.A. Yoho, K. Hayes, M.Z. Fissha, and U.S. Tantry Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study J Am Coll Cardiol 46 2005 1827 1832 (Pubitemid 41579803)
17. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J. Ruven, E.T. Bal, V.H. Deneer, A.M. Harmsze, J.A. van der Heyden, B.J. Rensing, M.J. Suttorp, C.M. Hackeng, and J.M. ten Berg Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
18. W.H. Chen, P.Y. Lee, W. Ng, H.F. Tse, and C.P. Lau Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J Am Coll Cardiol 43 2004 1122 1126 (Pubitemid 38353000)
19. E.I. Lev, R.T. Patel, K.J. Maresh, S. Guthikonda, J. Granada, T. DeLao, P.F. Bray, and N.S. Kleiman Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance J Am Coll Cardiol 47 2006 27 33 (Pubitemid 43005160)
20. E.I. Lev, A. Solodky, N. Harel, A. Mager, D. Brosh, A. Assali, M. Roller, A. Battler, N.S. Kleiman, and R. Kornowski Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation J Am Coll Cardiol 55 2010 114 121
21. N. Bonello-Palot, S. Armero, F. Paganelli, J. Mancini, A. De Labriolle, C. Bonello, N. Lévy, L. Maillard, P. Barragan, F. Dignat-George, L. Camoin-Jau, and L. Bonello Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention Am J Cardiol 104 2009 1511 1515
22. L. Ang, V. Palakodeti, A. Khalid, S. Tsimikas, Z. Idrees, P. Tran, P. Clopton, N. Zafar, G. Bromberg-Marin, S. Keramati, and E. Mahmud Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel J Am Coll Cardiol 52 2008 1052 1059
23. M. Tamminen, R. Lassila, J. Westerbacka, S. Vehkavaara, and H. Yki-Jrvinen Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects Int J Obes Relat Metab Disord 27 2003 907 911 (Pubitemid 36918612)
24. J. Takaya, Y. Iwamoto, H. Higashino, M. Kino, T. Kobayashi, and Y. Kobayashi Altered intracellular calcium and phorbol 12,13-dibutyrate binding to intact platelets in young obese subjects J Lab Clin Med 129 1997 245 250 (Pubitemid 27134071)
25. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977 (Pubitemid 13080473)
26. A. Oreopoulos, R. Padwal, C.M. Norris, J.C. Mullen, V. Pretorius, and K. Kalantar-Zadeh Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis Obesity (Silver Spring) 16 2008 442 450 (Pubitemid 351271929)
27. O. Morel, S. El Ghannudi, L. Jesel, B. Radulescu, N. Meyer, M.L. Wiesel, S. Caillard, U. Campia, B. Moulin, C. Gachet, and P. Ohlmann Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel J Am Coll Cardiol 57 2011 399 408
28. K.P. Bliden, J. Dichiara, L. Lawal, A. Singla, M.J. Antonino, B.A. Baker, W.L. Bailey, U.S. Tantry, and P.A. Gurbel The association of cigarette smoking with enhanced platelet inhibition by clopidogrel J Am Coll Cardiol 52 2008 531 533
29. T. Gremmel, S. Steiner, D. Seidinger, R. Koppensteiner, S. Panzer, and C.W. Kopp Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel J Thromb Haemost 8 2010 37 42
30. M. Gilard, B. Arnaud, J.C. Cornily, G. Le Gal, K. Lacut, G. Le Calvez, J. Mansourati, D. Mottier, J.F. Abgrall, and J. Boschat Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 51 2008 256 260
31. S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford, C.C. Lang, Z. Rumboldt, C.L. Onen, L. Lisheng, S. Tanomsup, P. Wangai Jr, F. Razak, A.M. Sharma, and S.S. Anand Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study Lancet 366 2005 1640 1649 (Pubitemid 41552419)